Spring 2005
download entire issue in
 format
|
For past issues of the MAPS Bulletin, see the archives.
Html versions of each article can be seen by clicking on the titles.
|
| |
Front Cover
|
| |
Inside Front Cover
|
| |
Table of contents
|
| 2 |
Letter from Rick Doblin, MAPS President
|
| 3 |
MDMA-Assisted Psychotherapy in the Treatment of Post Traumatic Stress Disorder, an Update
by Michael Mithoefer, MD
|
| 4 |
MAPS' Medical Marijuana Research Efforts
by Rick Doblin, PhD
|
| 6 |
MDMA-Assisted Psychotherapy in the Treatment of Anxiety in Advanced Cancer Patients
by John Halpern, MD
|
| 7 |
MDMA and Basic Research: Issues Within and Beyond Therapeutic Applications
by Ilsa Jerome, PhD
|
| 13 |
Neurocognitive Profile of Long Term Ecstasy Users, Proposed Research
by Philipp Ruessli
|
| 14 |
Making Connections: MDMA Research on Mechanisms of Affiliation and Trust
by Alan Fiske, PhD
|
| 17 |
Why I Support the Pill Testing Program (and you should too)
by Adam Wiggins
|
| 18 |
LSD and Psilocybin in the Treatment of Cluster Headaches
by R. Andrew Sewell, MD
|
| 19 |
Ayahuasca/EEG Research Progress Report and Invitation to Donate
by Frank Echenhoffer, PhD
|
| 21 |
Ibogaine in the 21st Century: Boosters, Tune-ups and Maintenance
by Patrick K. Kroupa and Hattie Wells
|
| 25 |
Ibogaine Outcome Study Progress Report
by Valerie Mojeiko
|
| 27 |
A Psychedelic Neurochemistry of Time
by Kim A. Dawson, PhD
|
| 30 |
Towards a Psychospiritual Understanding of Psychedelic Therapy: A Dissertation
by Sean G. House, PhD
|
| 32 |
Heffter Research Institute: Update Spring 2005
by Dave Nichols, PhD
|
| 34 |
The MAPS Online Benefit Auction
|
| 35 |
The Albert Hofmann Foundation Report
by Myron Stolaroff
|
| 37 |
Reducing Harm and Enhancing Benefit: A Report on MAPS at Burning Man 2004
by Brandy Doyle
|
| 39 |
From a Sanctuary Client
|
| 41 |
Letters to MAPS
|
| |
Inside Back Cover
|
| |
Back Cover
|
|
|
MAPS (Multidisciplinary Association for
Psychedelic Studies) is a membership-based
organization working to assist researchers
worldwide to design, fund, conduct, obtain
governmental approval for, and report on
psychedelic research in humans. Founded in 1986,
MAPS is an IRS approved 501 (c)(3) non-profit
corporation funded by tax deductible
donations.
MAPS is focused primarily on
assisting scientists to conduct human studies to
generate essential information about the risks and
psychotherapeutic benefits of MDMA, other
psychedelics, and marijuana, with the goal of
eventually gaining government approval for
their medical uses.
Interested parties wishing to
copy any portion of this publication are encouraged
to do so and are kindly requested to credit
MAPS and include our address. The MAPS Bulletin
is produced by a small group of dedicated staff
and volunteers. Your participation, financial or
otherwise, is welcome.
|
© 2005 Multidisciplinary Association
for Psychedelic Studies, Inc. (MAPS)
2105 Robinson Avenue,
Sarasota, FL 34232
Phone: 941-924-6277;
Toll-Free: 888-868-MAPS
Fax: 941-924-6265
Web: http://www.maps.org
|
ISSN 1080-8981
Printed on recycled paper
|
|